Integrated MRI-RT platforms offer precise and effective visualization of patient’s anatomical and physiological changes; that results in greater procedural accuracy and improved therapeutic outcome
Tag: Medical Devices
Guardant Health and AstraZeneca to develop companion diagnostics (CDx) and liquid biopsy tests
On Dec 13, 2018 AstraZeneca, a global research based biopharmaceutical company, partnered with Guardant Health (US) for the development of CDx tests to commercialize AstraZeneca’s oncology portfolio including Tagrisso and Imfinzi. The CDx test is based on liquid biopsy platform supported by Guardant’s proprietary Digital Sequencing technology.